“And our expectation is the businesses will work to offset that inflation growth.”

In context

“n again in 2022 and another $2 billion in 2023, so more than exceeding the level that we thought about and talked about last year. That obviously is the structural side of the equation in terms of reducing cost. The counterweight then is the inflation and Forex and some of the pressures that we’re seeing. In the short-term, we were in the down cycle. We recognize that there would be a return and there would be growth, and that would put pressure on prices. And so we, in anticipation of that, tried to manage many of our contracts and the work that we are doing to maintain a level of cost and to minimize escalation as we headed into 2021 and into 2022, and that’s paying off. We’ve managed to mitigate quite a bit of that inflation. Obviously, as time goes on, we’ll start to see more of that. And our expectation is the businesses will work to offset that inflation growth. And longer-term, our objective is, as we grow the business with the investments that we’re making in Chemical business, Chemical facilities and some of the changes that we’re making in our downstream operations, and then as we grow some of the upstream businesses, we’ll offset all that increased cost with structural efficiencies. Biraj Borkhataria: Okay, understood. That’s very helpful. The second question is actually asset specific. I’ve been looking at some of the export data at Papua New Guinea over the last few months, and it looks like that asset is performing extremely well and above nameplate capacity. I was wondering if you could talk about whether there’s anything specific you’re doing to increase capacity there? And maybe any color on how much of those exports are contracted ver”